Healthcare -
Biotechnology - NASDAQ - US
$ 0.6625
-2.17 %
$ 51.8 M
Market Cap
4.14
P/E
CTMX - GROSS PROFIT
Gross Profit CTMX - CytomX Therapeutics, Inc.
101 M
LAST VALUE
26.02%
2 YEAR CAGR
11.21%
5 YEAR CAGR
60.58%
10 YEAR CAGR